Back
Enliven Therapeutics Stock Price Chart
Buy
61
ELVN
Enliven Therapeutics
Last Price:
23.05
Seasonality Move:
-14.92%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and ELVN is experiencing selling pressure, which indicates risk of future bearish movement.
Enliven Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.87 | Sell |
| 20-day SMA: | 21.1 | Buy |
| 50-day SMA: | 18.88 | Buy |
| 200-day SMA: | 15.36 | Buy |
| 8-day EMA: | 23.38 | Sell |
| 20-day EMA: | 21.91 | Buy |
| 50-day EMA: | 19.67 | Buy |
| 200-day EMA: | 16.75 | Buy |
Enliven Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 58.89 | Buy |
| Chaikin Money Flow: | -168921 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.49 - 23.53) | Buy |
| Bollinger Bands (100): | (13.77 - 20.29) | Buy |
Enliven Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics Stock
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 23.04 while ELVN 8-day simple moving average is 23.87, which is a Sell signal.
- The stock price of ELVN is 23.04 while Enliven Therapeutics 20-day SMA is 21.10, which makes it a Buy.
- Enliven Therapeutics 50-day simple moving average is 18.88 while ELVN share price is 23.04, making it a Buy technically.
- ELVN stock price is 23.04 and Enliven Therapeutics 200-day simple moving average is 15.36, creating a Buy signal.
ELVN Technical Analysis vs Fundamental Analysis
Buy
61
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy or a Sell?
-
Enliven Therapeutics stock is rated a Buy
The current Enliven Therapeutics [ELVN] share price is $23.04. The Score for ELVN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
Enliven Therapeutics Stock Info
Market Cap:
1.08B
Price in USD:
23.04
Share Volume:
216.73K
Enliven Therapeutics 52-Week Range
52-Week High:
26.00
52-Week Low:
9.80
Buy
61
Enliven Therapeutics (ELVN)
is a Buy
Enliven Therapeutics Share Price Forecast
-
What is the Enliven Therapeutics stock price today?
The Enliven Therapeutics stock price is 23.04 USD today. -
Will ELVN stock go up or go down?
Enliven Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enliven Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics is not overvalued.
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 23.04 while ELVN 8-day exponential moving average is 23.38, which is a Sell signal.
- The stock price of ELVN is 23.04 while Enliven Therapeutics 20-day EMA is 21.91, which makes it a Buy.
- Enliven Therapeutics 50-day exponential moving average is 19.67 while ELVN share price is 23.04, making it a Buy technically.
- ELVN stock price is 23.04 and Enliven Therapeutics 200-day simple moving average is 16.75, creating a Buy signal.
Fundamental Analysis of Enliven Therapeutics
Is Enliven Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Enliven Therapeutics
Should I short Enliven Therapeutics stock?
- ELVN Moving Average Covergence Divergence (MACD) indicator is 1.55, suggesting Enliven Therapeutics is a Buy
- Enliven Therapeutics Relative Strength Index (RSI) is 58.89, which suggest Enliven Therapeutics is overbought
- The Bollinger Bands (25) for Enliven Therapeutics is (17.49 - 23.53), which suggest Enliven Therapeutics is a Buy
- The Bollinger Bands (100) for Enliven Therapeutics is (13.77 - 20.29), which suggest Enliven Therapeutics is a Buy
* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.